Clinical Trials Logo

Porphyria, Acute Intermittent clinical trials

View clinical trials related to Porphyria, Acute Intermittent.

Filter by:

NCT ID: NCT00418795 Completed - Clinical trials for Acute Intermittent Porphyria

Porphozym in the Treatment of Acute Attacks in AIP

Start date: June 11, 2003
Phase: Phase 2/Phase 3
Study type: Interventional

A multi-centre, double-blind, randomized, placebo controlled, parallel group trial, investigating the efficacy and safety of Porphozym (recombinant human porphobilinogen deaminase)in the treatment of acute attacks in AIP.